AI-generated analysis. Always verify with the original filing.
Skye Bioscience, Inc. filed an 8-K on February 20, 2026, with Items listed as N/A. An external hint references Item 5.02 regarding a potential departure, election, or appointment of directors or certain officers effective February 1, but no specific details are disclosed in the document content.
Event Type
Disclosure
Mandatory
Variant
8-K
Departure of Directors or Certain Officers; Election of Directors, Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February 1